Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Evaluating Single Agent Indocyanine Green as an Alternative to Dual Dye‐Tracer Mapping in Sentinel Lymph Node Biopsy for Breast Cancer: A Two‐Arm Open‐Label Randomized Controlled Trial
1
Zitationen
11
Autoren
2026
Jahr
Abstract
This study is registered under Clinical Trials Registry-India (CTRI) vide registration no. CTRI/2022/09/045719.
Ähnliche Arbeiten
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
2000 · 15.689 Zit.
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 · 13.204 Zit.
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 · 10.886 Zit.
Gene expression profiling predicts clinical outcome of breast cancer
2002 · 9.572 Zit.
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
2005 · 7.584 Zit.